| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antiviral Agents | 6 | 2024 | 510 | 2.080 |
Why?
|
| Salicylates | 3 | 2024 | 25 | 1.760 |
Why?
|
| Herpes Simplex | 2 | 2021 | 202 | 1.420 |
Why?
|
| Herpesvirus 1, Human | 2 | 2021 | 244 | 1.310 |
Why?
|
| Herpesvirus 6, Human | 4 | 2010 | 19 | 1.250 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2022 | 50 | 1.060 |
Why?
|
| Virus Diseases | 2 | 2024 | 97 | 0.990 |
Why?
|
| Herpesvirus 4, Human | 2 | 2022 | 114 | 0.990 |
Why?
|
| Viral Envelope Proteins | 2 | 2020 | 94 | 0.960 |
Why?
|
| Virus Replication | 4 | 2021 | 319 | 0.840 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2022 | 74 | 0.840 |
Why?
|
| Betaherpesvirinae | 1 | 2021 | 1 | 0.820 |
Why?
|
| Complement Inactivating Agents | 1 | 2021 | 4 | 0.820 |
Why?
|
| Herpesviridae Infections | 1 | 2021 | 46 | 0.800 |
Why?
|
| Virus Latency | 1 | 2021 | 33 | 0.800 |
Why?
|
| Immune Evasion | 1 | 2021 | 33 | 0.800 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2021 | 64 | 0.770 |
Why?
|
| Dermatitis | 1 | 2021 | 32 | 0.770 |
Why?
|
| Immunity | 1 | 2021 | 136 | 0.750 |
Why?
|
| RNA Virus Infections | 1 | 2020 | 3 | 0.750 |
Why?
|
| DNA Viruses | 1 | 2020 | 16 | 0.750 |
Why?
|
| DNA Virus Infections | 1 | 2020 | 6 | 0.750 |
Why?
|
| Viral Fusion Proteins | 1 | 2020 | 10 | 0.740 |
Why?
|
| RNA Viruses | 1 | 2020 | 9 | 0.740 |
Why?
|
| Stomach Neoplasms | 1 | 2022 | 266 | 0.720 |
Why?
|
| Stress, Psychological | 1 | 2021 | 313 | 0.650 |
Why?
|
| Peptides | 1 | 2021 | 639 | 0.630 |
Why?
|
| Genetic Vectors | 3 | 2010 | 439 | 0.550 |
Why?
|
| DNA Replication | 2 | 2020 | 164 | 0.510 |
Why?
|
| Fertilization in Vitro | 9 | 1994 | 54 | 0.510 |
Why?
|
| Genome, Viral | 2 | 2010 | 74 | 0.440 |
Why?
|
| Embryo Transfer | 8 | 1993 | 29 | 0.410 |
Why?
|
| T-Lymphocytes | 4 | 2010 | 1195 | 0.390 |
Why?
|
| Pregnancy | 44 | 1993 | 2893 | 0.380 |
Why?
|
| Vero Cells | 2 | 2021 | 100 | 0.380 |
Why?
|
| Signal Transduction | 1 | 2021 | 3241 | 0.370 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2010 | 135 | 0.350 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 646 | 0.330 |
Why?
|
| Exons | 1 | 2010 | 450 | 0.320 |
Why?
|
| Pregnancy, Multiple | 5 | 1993 | 37 | 0.320 |
Why?
|
| Humans | 87 | 2024 | 86601 | 0.310 |
Why?
|
| Base Sequence | 2 | 2010 | 2330 | 0.300 |
Why?
|
| Ovulation | 7 | 1990 | 68 | 0.300 |
Why?
|
| Herpesvirus 7, Human | 1 | 2006 | 3 | 0.290 |
Why?
|
| Cell Line | 4 | 2021 | 2468 | 0.290 |
Why?
|
| Cesarean Section | 8 | 1993 | 137 | 0.280 |
Why?
|
| Gene Amplification | 1 | 2006 | 131 | 0.280 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 2232 | 0.270 |
Why?
|
| Helper Viruses | 1 | 2004 | 1 | 0.250 |
Why?
|
| Metapneumovirus | 1 | 2024 | 3 | 0.250 |
Why?
|
| Paramyxoviridae Infections | 1 | 2024 | 5 | 0.250 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2024 | 6 | 0.250 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2024 | 23 | 0.250 |
Why?
|
| Animals | 10 | 2021 | 26581 | 0.240 |
Why?
|
| Twins | 6 | 1993 | 65 | 0.230 |
Why?
|
| Abortion, Therapeutic | 2 | 1993 | 11 | 0.230 |
Why?
|
| Respiratory Tract Infections | 1 | 2024 | 105 | 0.230 |
Why?
|
| Nasopharynx | 1 | 2022 | 47 | 0.220 |
Why?
|
| DNA, Viral | 2 | 2020 | 265 | 0.210 |
Why?
|
| Thymidine Kinase | 1 | 2021 | 30 | 0.200 |
Why?
|
| CD40 Antigens | 1 | 2021 | 43 | 0.200 |
Why?
|
| Drug Resistance, Viral | 1 | 2021 | 51 | 0.200 |
Why?
|
| CD40 Ligand | 1 | 2021 | 69 | 0.200 |
Why?
|
| Adult | 58 | 2024 | 25640 | 0.200 |
Why?
|
| Pregnancy, Tubal | 2 | 1993 | 4 | 0.200 |
Why?
|
| Viral Plaque Assay | 1 | 2021 | 19 | 0.200 |
Why?
|
| Female | 78 | 2018 | 44507 | 0.200 |
Why?
|
| Acyclovir | 1 | 2021 | 107 | 0.200 |
Why?
|
| Infertility, Female | 8 | 1990 | 92 | 0.190 |
Why?
|
| Hemoperitoneum | 2 | 1991 | 4 | 0.190 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2021 | 122 | 0.180 |
Why?
|
| Virus Internalization | 1 | 2020 | 39 | 0.180 |
Why?
|
| HEK293 Cells | 2 | 2020 | 615 | 0.180 |
Why?
|
| Virion | 1 | 2020 | 59 | 0.180 |
Why?
|
| Mice | 5 | 2021 | 11352 | 0.180 |
Why?
|
| Down-Regulation | 1 | 2021 | 504 | 0.180 |
Why?
|
| Ovarian Follicle | 2 | 1990 | 72 | 0.180 |
Why?
|
| Turkeys | 1 | 1999 | 2 | 0.180 |
Why?
|
| Astrocytes | 1 | 2020 | 139 | 0.180 |
Why?
|
| Poultry Diseases | 1 | 1999 | 13 | 0.180 |
Why?
|
| Autophagy | 1 | 2021 | 149 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 1047 | 0.170 |
Why?
|
| Seizures | 1 | 2021 | 295 | 0.170 |
Why?
|
| Retroviridae Infections | 1 | 1999 | 48 | 0.170 |
Why?
|
| Tumor Virus Infections | 1 | 1999 | 81 | 0.170 |
Why?
|
| Chickens | 1 | 1999 | 212 | 0.170 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2018 | 2 | 0.170 |
Why?
|
| Channelopathies | 1 | 2018 | 4 | 0.170 |
Why?
|
| Oxidative Stress | 1 | 2021 | 447 | 0.160 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2018 | 23 | 0.160 |
Why?
|
| Uterine Rupture | 3 | 1993 | 4 | 0.160 |
Why?
|
| Pyramidal Cells | 1 | 2018 | 80 | 0.160 |
Why?
|
| Pregnancy, Ectopic | 3 | 1992 | 36 | 0.160 |
Why?
|
| Clomiphene | 4 | 1990 | 18 | 0.150 |
Why?
|
| Ovulation Induction | 5 | 1990 | 33 | 0.150 |
Why?
|
| Suction | 3 | 1992 | 35 | 0.140 |
Why?
|
| Superovulation | 2 | 1990 | 9 | 0.140 |
Why?
|
| Obstetric Labor Complications | 2 | 1989 | 34 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 187 | 0.140 |
Why?
|
| Birth Weight | 6 | 1993 | 145 | 0.130 |
Why?
|
| Fallopian Tubes | 2 | 1993 | 41 | 0.130 |
Why?
|
| Corpus Luteum | 3 | 1991 | 14 | 0.130 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1578 | 0.130 |
Why?
|
| Delivery, Obstetric | 6 | 1993 | 112 | 0.130 |
Why?
|
| Pandemics | 1 | 2021 | 740 | 0.130 |
Why?
|
| Bromocriptine | 4 | 1986 | 12 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 470 | 0.120 |
Why?
|
| Pregnancy Complications, Neoplastic | 2 | 1991 | 28 | 0.120 |
Why?
|
| Pre-Eclampsia | 2 | 1992 | 246 | 0.120 |
Why?
|
| Dinoprostone | 1 | 1993 | 69 | 0.120 |
Why?
|
| Necrosis | 3 | 2012 | 204 | 0.120 |
Why?
|
| Ovarian Neoplasms | 5 | 1990 | 744 | 0.120 |
Why?
|
| Pregnancy Complications | 5 | 1993 | 336 | 0.120 |
Why?
|
| Fallopian Tube Diseases | 1 | 1993 | 4 | 0.110 |
Why?
|
| Pregnancy Outcome | 2 | 1992 | 247 | 0.110 |
Why?
|
| Fasciotomy | 1 | 1992 | 16 | 0.110 |
Why?
|
| Oxytocin | 1 | 1993 | 71 | 0.110 |
Why?
|
| Hysterectomy, Vaginal | 1 | 1992 | 14 | 0.110 |
Why?
|
| Sirtuin 2 | 1 | 2012 | 9 | 0.110 |
Why?
|
| Prolactin | 4 | 1986 | 88 | 0.110 |
Why?
|
| Laparoscopy | 2 | 1990 | 754 | 0.110 |
Why?
|
| Infant, Newborn | 15 | 1993 | 2378 | 0.110 |
Why?
|
| Breech Presentation | 2 | 1993 | 12 | 0.110 |
Why?
|
| Ovarian Diseases | 2 | 1989 | 32 | 0.100 |
Why?
|
| Cystadenocarcinoma | 1 | 1991 | 12 | 0.100 |
Why?
|
| Embryonic and Fetal Development | 2 | 1990 | 72 | 0.100 |
Why?
|
| Rheumatic Heart Disease | 1 | 1991 | 29 | 0.100 |
Why?
|
| Erythroblastosis, Fetal | 1 | 1990 | 7 | 0.100 |
Why?
|
| Rh Isoimmunization | 1 | 1990 | 7 | 0.100 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 1990 | 18 | 0.100 |
Why?
|
| Adenocarcinoma, Scirrhous | 1 | 1990 | 1 | 0.090 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 3030 | 0.090 |
Why?
|
| Premenstrual Syndrome | 1 | 1990 | 2 | 0.090 |
Why?
|
| Gamete Intrafallopian Transfer | 1 | 1990 | 3 | 0.090 |
Why?
|
| Erythrocyte Transfusion | 1 | 1991 | 60 | 0.090 |
Why?
|
| Warfarin | 1 | 1991 | 103 | 0.090 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 3 | 1994 | 5 | 0.090 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2009 | 20 | 0.090 |
Why?
|
| Puerperal Disorders | 3 | 1993 | 32 | 0.090 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2009 | 30 | 0.090 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 1990 | 48 | 0.090 |
Why?
|
| Labor Presentation | 1 | 1989 | 4 | 0.090 |
Why?
|
| Blotting, Southern | 1 | 2009 | 129 | 0.090 |
Why?
|
| Jurkat Cells | 2 | 2012 | 77 | 0.090 |
Why?
|
| Open Reading Frames | 1 | 2010 | 117 | 0.090 |
Why?
|
| Menotropins | 6 | 1990 | 21 | 0.090 |
Why?
|
| Intrauterine Devices | 1 | 1989 | 28 | 0.090 |
Why?
|
| Isoantibodies | 1 | 1990 | 114 | 0.090 |
Why?
|
| Chorionic Gonadotropin | 7 | 1994 | 72 | 0.090 |
Why?
|
| Contraception | 1 | 1989 | 88 | 0.080 |
Why?
|
| Uterus | 2 | 1989 | 215 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1991 | 275 | 0.080 |
Why?
|
| Tamoxifen | 1 | 1989 | 168 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 425 | 0.080 |
Why?
|
| Uterine Neoplasms | 3 | 1991 | 226 | 0.080 |
Why?
|
| Leiomyoma | 1 | 1991 | 190 | 0.070 |
Why?
|
| Adrenal Cortex Neoplasms | 2 | 1987 | 18 | 0.070 |
Why?
|
| Estradiol | 4 | 1992 | 252 | 0.070 |
Why?
|
| Umbilical Cord | 2 | 1982 | 40 | 0.070 |
Why?
|
| Disorders of Sex Development | 1 | 1985 | 18 | 0.070 |
Why?
|
| Ultrasonography | 3 | 1993 | 695 | 0.060 |
Why?
|
| Anovulation | 2 | 1982 | 10 | 0.060 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 1988 | 68 | 0.060 |
Why?
|
| Alkaline Phosphatase | 2 | 1988 | 132 | 0.060 |
Why?
|
| Transgenes | 1 | 2004 | 180 | 0.060 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 144 | 0.060 |
Why?
|
| Serum Albumin | 2 | 1994 | 130 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 305 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2004 | 329 | 0.060 |
Why?
|
| Cervix Mucus | 2 | 1982 | 4 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 1990 | 2436 | 0.060 |
Why?
|
| Adenoma | 1 | 1985 | 235 | 0.060 |
Why?
|
| Israel | 4 | 1992 | 55 | 0.050 |
Why?
|
| Progesterone | 3 | 1992 | 110 | 0.050 |
Why?
|
| Dermoid Cyst | 1 | 1982 | 15 | 0.050 |
Why?
|
| Ritodrine | 1 | 1982 | 1 | 0.050 |
Why?
|
| Diagnosis, Differential | 4 | 1999 | 1565 | 0.050 |
Why?
|
| Ovulation Detection | 1 | 1982 | 6 | 0.050 |
Why?
|
| Uterine Contraction | 1 | 1982 | 9 | 0.050 |
Why?
|
| Propanolamines | 1 | 1982 | 36 | 0.050 |
Why?
|
| Pentylenetetrazole | 1 | 2021 | 2 | 0.050 |
Why?
|
| Mice, 129 Strain | 1 | 2021 | 55 | 0.050 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1982 | 100 | 0.050 |
Why?
|
| Status Epilepticus | 1 | 2021 | 31 | 0.050 |
Why?
|
| Indomethacin | 3 | 1989 | 59 | 0.050 |
Why?
|
| Parkinson Disease | 2 | 1993 | 132 | 0.050 |
Why?
|
| Ovary | 3 | 1979 | 257 | 0.050 |
Why?
|
| Blood Transfusion | 3 | 1991 | 157 | 0.050 |
Why?
|
| Luteinizing Hormone | 5 | 1990 | 167 | 0.050 |
Why?
|
| Parity | 3 | 1990 | 93 | 0.050 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1980 | 24 | 0.050 |
Why?
|
| Sodium Chloride | 1 | 1980 | 86 | 0.040 |
Why?
|
| Gene Expression | 1 | 2004 | 1284 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 3 | 1993 | 66 | 0.040 |
Why?
|
| Herpesvirus 2, Gallid | 1 | 1999 | 1 | 0.040 |
Why?
|
| Marek Disease | 1 | 1999 | 2 | 0.040 |
Why?
|
| Oncogenic Viruses | 1 | 1999 | 4 | 0.040 |
Why?
|
| Terminal Repeat Sequences | 1 | 1999 | 9 | 0.040 |
Why?
|
| Fetal Death | 3 | 1993 | 56 | 0.040 |
Why?
|
| Leucyl Aminopeptidase | 1 | 1979 | 2 | 0.040 |
Why?
|
| Hexosaminidases | 1 | 1979 | 7 | 0.040 |
Why?
|
| Acetylglucosaminidase | 1 | 1979 | 5 | 0.040 |
Why?
|
| Maternal Age | 3 | 1989 | 44 | 0.040 |
Why?
|
| Endometrium | 3 | 1992 | 48 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 1979 | 73 | 0.040 |
Why?
|
| Retroviridae | 1 | 1999 | 79 | 0.040 |
Why?
|
| Proteins | 1 | 2004 | 777 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 1999 | 265 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 376 | 0.040 |
Why?
|
| Hippocampus | 1 | 2021 | 442 | 0.040 |
Why?
|
| Apgar Score | 2 | 1987 | 13 | 0.040 |
Why?
|
| Infant | 1 | 2024 | 3045 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2004 | 1196 | 0.040 |
Why?
|
| Abortion, Induced | 1 | 1980 | 120 | 0.040 |
Why?
|
| Fertilization | 4 | 1990 | 40 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2024 | 3611 | 0.040 |
Why?
|
| Thrombophlebitis | 1 | 1976 | 25 | 0.040 |
Why?
|
| Oligomenorrhea | 2 | 1990 | 11 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 1999 | 927 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2021 | 1924 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 250 | 0.040 |
Why?
|
| Aged | 5 | 2024 | 18402 | 0.040 |
Why?
|
| Follicle Stimulating Hormone | 4 | 1990 | 147 | 0.030 |
Why?
|
| Time Factors | 5 | 1992 | 5209 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1801 | 0.030 |
Why?
|
| Hydroxyprogesterones | 2 | 1985 | 22 | 0.030 |
Why?
|
| Prevalence | 1 | 1999 | 1239 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 3092 | 0.030 |
Why?
|
| Action Potentials | 1 | 2018 | 573 | 0.030 |
Why?
|
| Neurons | 2 | 2021 | 1546 | 0.030 |
Why?
|
| Male | 6 | 2021 | 40956 | 0.030 |
Why?
|
| Infant Mortality | 2 | 1992 | 59 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 1540 | 0.030 |
Why?
|
| Shock | 1 | 1993 | 42 | 0.030 |
Why?
|
| Aging | 1 | 2018 | 691 | 0.030 |
Why?
|
| Torsion Abnormality | 1 | 1993 | 17 | 0.030 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2012 | 5 | 0.030 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2012 | 13 | 0.030 |
Why?
|
| Rectal Prolapse | 1 | 1992 | 8 | 0.030 |
Why?
|
| Urinary Bladder Diseases | 1 | 1992 | 41 | 0.030 |
Why?
|
| Acetylation | 1 | 2012 | 121 | 0.030 |
Why?
|
| Child | 1 | 2024 | 6926 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 2270 | 0.030 |
Why?
|
| Peritoneum | 2 | 1990 | 57 | 0.030 |
Why?
|
| Uterine Prolapse | 1 | 1992 | 77 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 1992 | 115 | 0.030 |
Why?
|
| Methotrexate | 1 | 1992 | 249 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2012 | 498 | 0.030 |
Why?
|
| Methods | 2 | 1986 | 152 | 0.020 |
Why?
|
| Lipids | 1 | 1972 | 269 | 0.020 |
Why?
|
| Testosterone | 1 | 1972 | 271 | 0.020 |
Why?
|
| Chlormadinone Acetate | 1 | 1970 | 2 | 0.020 |
Why?
|
| Mestranol | 1 | 1970 | 4 | 0.020 |
Why?
|
| Urinary Incontinence, Stress | 1 | 1992 | 192 | 0.020 |
Why?
|
| Epithelium | 2 | 1990 | 319 | 0.020 |
Why?
|
| Peptichemio | 1 | 1990 | 1 | 0.020 |
Why?
|
| Dementia | 1 | 1992 | 187 | 0.020 |
Why?
|
| Cephalothin | 1 | 1990 | 2 | 0.020 |
Why?
|
| Dinoprost | 1 | 1990 | 26 | 0.020 |
Why?
|
| Diet Therapy | 1 | 1990 | 20 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 1970 | 46 | 0.020 |
Why?
|
| Heart Valve Prosthesis | 1 | 1991 | 93 | 0.020 |
Why?
|
| Povidone-Iodine | 1 | 1990 | 8 | 0.020 |
Why?
|
| Thymus Hormones | 1 | 1990 | 2 | 0.020 |
Why?
|
| Intrauterine Devices, Copper | 1 | 1990 | 3 | 0.020 |
Why?
|
| Gestational Age | 2 | 1989 | 311 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1990 | 50 | 0.020 |
Why?
|
| Tachycardia | 1 | 1990 | 35 | 0.020 |
Why?
|
| Contraceptive Agents | 1 | 1990 | 20 | 0.020 |
Why?
|
| Hormones | 1 | 1990 | 140 | 0.020 |
Why?
|
| Microscopy | 1 | 1990 | 87 | 0.020 |
Why?
|
| Copper | 1 | 1990 | 71 | 0.020 |
Why?
|
| Recurrence | 1 | 1992 | 1139 | 0.020 |
Why?
|
| Abortion, Missed | 1 | 1989 | 1 | 0.020 |
Why?
|
| Pelvis | 1 | 1990 | 95 | 0.020 |
Why?
|
| Middle Aged | 10 | 1992 | 25017 | 0.020 |
Why?
|
| Plasma Substitutes | 1 | 1989 | 9 | 0.020 |
Why?
|
| Psychotropic Drugs | 1 | 1990 | 75 | 0.020 |
Why?
|
| Length of Stay | 1 | 1992 | 700 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 1990 | 299 | 0.020 |
Why?
|
| Electrolytes | 1 | 1989 | 52 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1989 | 274 | 0.020 |
Why?
|
| Doxorubicin | 1 | 1990 | 295 | 0.020 |
Why?
|
| Silicones | 1 | 1989 | 16 | 0.020 |
Why?
|
| Ascites | 1 | 1989 | 55 | 0.020 |
Why?
|
| Cysts | 1 | 1990 | 104 | 0.020 |
Why?
|
| Bandages | 1 | 1989 | 41 | 0.020 |
Why?
|
| Adnexal Diseases | 1 | 1989 | 17 | 0.020 |
Why?
|
| Mitral Valve | 1 | 1991 | 248 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 1456 | 0.020 |
Why?
|
| Leukemia, Lymphoid | 1 | 1988 | 72 | 0.020 |
Why?
|
| Dysgerminoma | 1 | 1988 | 7 | 0.020 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 2 | 1985 | 31 | 0.020 |
Why?
|
| Drainage | 1 | 1989 | 157 | 0.020 |
Why?
|
| Syndrome | 1 | 1989 | 446 | 0.020 |
Why?
|
| Mediastinal Neoplasms | 1 | 1988 | 46 | 0.020 |
Why?
|
| Incidence | 1 | 1992 | 1576 | 0.020 |
Why?
|
| Anesthesia | 1 | 1990 | 164 | 0.020 |
Why?
|
| Colforsin | 1 | 1987 | 74 | 0.020 |
Why?
|
| Probability | 1 | 1989 | 355 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1990 | 464 | 0.020 |
Why?
|
| Birth Order | 1 | 1987 | 8 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 1992 | 2207 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 1987 | 146 | 0.020 |
Why?
|
| Adolescent | 5 | 1993 | 8979 | 0.020 |
Why?
|
| Ergolines | 1 | 1986 | 8 | 0.020 |
Why?
|
| Hyperprolactinemia | 1 | 1986 | 5 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1988 | 460 | 0.020 |
Why?
|
| Dopamine Antagonists | 1 | 1986 | 35 | 0.020 |
Why?
|
| Abortion, Spontaneous | 1 | 1986 | 66 | 0.020 |
Why?
|
| Cortodoxone | 1 | 1985 | 2 | 0.020 |
Why?
|
| Cosyntropin | 1 | 1985 | 5 | 0.020 |
Why?
|
| Age Factors | 2 | 1985 | 1849 | 0.020 |
Why?
|
| Pregnadienes | 2 | 1974 | 2 | 0.020 |
Why?
|
| Cervix Uteri | 2 | 1990 | 65 | 0.020 |
Why?
|
| Obstetric Labor, Premature | 1 | 1985 | 58 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 1989 | 8475 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 1980 | 3636 | 0.010 |
Why?
|
| Foam Cells | 1 | 1983 | 17 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1985 | 298 | 0.010 |
Why?
|
| Curettage | 2 | 1980 | 12 | 0.010 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 1982 | 6 | 0.010 |
Why?
|
| Prolapse | 1 | 1982 | 10 | 0.010 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1982 | 14 | 0.010 |
Why?
|
| Asphyxia Neonatorum | 1 | 1982 | 7 | 0.010 |
Why?
|
| Amniocentesis | 1 | 1982 | 31 | 0.010 |
Why?
|
| Rheology | 1 | 1982 | 39 | 0.010 |
Why?
|
| Estrogens | 1 | 1983 | 200 | 0.010 |
Why?
|
| Edema | 1 | 1982 | 71 | 0.010 |
Why?
|
| Diseases in Twins | 1 | 1982 | 65 | 0.010 |
Why?
|
| Ovarian Cysts | 2 | 1979 | 17 | 0.010 |
Why?
|
| Labor, Obstetric | 2 | 1980 | 46 | 0.010 |
Why?
|
| Starch | 1 | 1981 | 8 | 0.010 |
Why?
|
| Estradiol Congeners | 1 | 1981 | 8 | 0.010 |
Why?
|
| Peritoneal Diseases | 1 | 1981 | 15 | 0.010 |
Why?
|
| Pericardial Effusion | 1 | 1981 | 19 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1991 | 2600 | 0.010 |
Why?
|
| Granuloma | 1 | 1981 | 65 | 0.010 |
Why?
|
| Galactorrhea | 1 | 1980 | 6 | 0.010 |
Why?
|
| Luteal Phase | 1 | 1980 | 14 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1981 | 130 | 0.010 |
Why?
|
| Menstruation Disturbances | 1 | 1980 | 24 | 0.010 |
Why?
|
| Macrophages | 1 | 1983 | 554 | 0.010 |
Why?
|
| Melanoma | 1 | 1963 | 454 | 0.010 |
Why?
|
| Labor, Induced | 1 | 1979 | 26 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 1979 | 66 | 0.010 |
Why?
|
| Bradycardia | 1 | 1978 | 39 | 0.010 |
Why?
|
| Prognosis | 1 | 1986 | 3674 | 0.010 |
Why?
|
| Vaginal Neoplasms | 1 | 1978 | 83 | 0.010 |
Why?
|
| Choristoma | 1 | 1978 | 68 | 0.010 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 1978 | 11 | 0.010 |
Why?
|
| Vulvar Neoplasms | 1 | 1978 | 20 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 1978 | 81 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 1978 | 104 | 0.010 |
Why?
|
| Genitalia, Female | 1 | 1976 | 25 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1980 | 1019 | 0.010 |
Why?
|
| Adenofibroma | 1 | 1974 | 5 | 0.010 |
Why?
|
| Contraceptives, Oral, Synthetic | 1 | 1974 | 6 | 0.010 |
Why?
|
| Random Allocation | 2 | 1986 | 332 | 0.010 |
Why?
|
| Gonadotropins, Pituitary | 1 | 1974 | 11 | 0.010 |
Why?
|
| Vaginal Smears | 2 | 1974 | 68 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1994 | 244 | 0.010 |
Why?
|
| Placebos | 1 | 1994 | 218 | 0.010 |
Why?
|
| Biopsy | 2 | 1992 | 1161 | 0.010 |
Why?
|
| Neurocognitive Disorders | 1 | 1992 | 13 | 0.010 |
Why?
|
| Diagnostic Techniques, Surgical | 1 | 1972 | 1 | 0.010 |
Why?
|
| Shock, Hemorrhagic | 1 | 1972 | 11 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1993 | 121 | 0.010 |
Why?
|
| Abdomen, Acute | 1 | 1972 | 20 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1993 | 303 | 0.010 |
Why?
|
| Fertility Agents, Female | 1 | 1992 | 4 | 0.010 |
Why?
|
| Embryo Implantation | 1 | 1992 | 25 | 0.010 |
Why?
|
| Laparotomy | 1 | 1972 | 59 | 0.010 |
Why?
|
| Postpartum Hemorrhage | 1 | 1972 | 24 | 0.010 |
Why?
|
| Brain | 2 | 1993 | 2216 | 0.010 |
Why?
|
| Phenotype | 2 | 1990 | 2377 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1992 | 118 | 0.010 |
Why?
|
| Prospective Studies | 2 | 1994 | 4210 | 0.010 |
Why?
|
| Lipoproteins | 1 | 1972 | 135 | 0.010 |
Why?
|
| Triglycerides | 1 | 1972 | 232 | 0.010 |
Why?
|
| Blood Coagulation Disorders | 1 | 1972 | 63 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 1992 | 218 | 0.010 |
Why?
|
| Cholesterol | 1 | 1972 | 356 | 0.010 |
Why?
|
| Menstrual Cycle | 1 | 1990 | 55 | 0.010 |
Why?
|
| Ceruloplasmin | 1 | 1990 | 9 | 0.010 |
Why?
|
| Immunocompetence | 1 | 1990 | 27 | 0.010 |
Why?
|
| Injections | 1 | 1990 | 109 | 0.010 |
Why?
|
| CD8 Antigens | 1 | 1990 | 82 | 0.010 |
Why?
|
| CD4 Antigens | 1 | 1990 | 83 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1990 | 95 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1990 | 90 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 1990 | 235 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1990 | 249 | 0.010 |
Why?
|
| Sex Factors | 1 | 1972 | 1054 | 0.010 |
Why?
|
| Tissue Adhesions | 1 | 1989 | 50 | 0.010 |
Why?
|
| Fetus | 1 | 1990 | 226 | 0.010 |
Why?
|
| Spleen | 1 | 1990 | 430 | 0.010 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 1988 | 8 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1988 | 130 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1990 | 989 | 0.010 |
Why?
|
| Guanylyl Imidodiphosphate | 1 | 1987 | 1 | 0.010 |
Why?
|
| Sodium Fluoride | 1 | 1987 | 3 | 0.010 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 1987 | 8 | 0.000 |
Why?
|
| NAD | 1 | 1987 | 65 | 0.000 |
Why?
|
| Manganese | 1 | 1987 | 53 | 0.000 |
Why?
|
| Rabbits | 1 | 1989 | 636 | 0.000 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1987 | 131 | 0.000 |
Why?
|
| Adenylyl Cyclases | 1 | 1987 | 100 | 0.000 |
Why?
|
| Isoenzymes | 1 | 1988 | 271 | 0.000 |
Why?
|
| Magnesium | 1 | 1987 | 177 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1987 | 256 | 0.000 |
Why?
|
| Wound Healing | 1 | 1989 | 344 | 0.000 |
Why?
|
| Pergolide | 1 | 1986 | 3 | 0.000 |
Why?
|
| Kinetics | 1 | 1987 | 1513 | 0.000 |
Why?
|
| Hydroxysteroids | 2 | 1974 | 11 | 0.000 |
Why?
|
| Oxazoles | 2 | 1974 | 19 | 0.000 |
Why?
|
| Alkynes | 2 | 1974 | 17 | 0.000 |
Why?
|
| Liver | 1 | 1990 | 1229 | 0.000 |
Why?
|
| Endometriosis | 2 | 1974 | 58 | 0.000 |
Why?
|
| Kidney | 1 | 1990 | 1241 | 0.000 |
Why?
|
| Endometrial Hyperplasia | 1 | 1983 | 8 | 0.000 |
Why?
|
| Uterine Hemorrhage | 1 | 1983 | 19 | 0.000 |
Why?
|
| Infant, Premature | 1 | 1985 | 290 | 0.000 |
Why?
|
| Amnion | 1 | 1982 | 14 | 0.000 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1982 | 76 | 0.000 |
Why?
|
| Platelet Count | 1 | 1982 | 92 | 0.000 |
Why?
|
| Peritonitis, Tuberculous | 1 | 1981 | 1 | 0.000 |
Why?
|
| Prednisone | 1 | 1982 | 258 | 0.000 |
Why?
|
| Zea mays | 1 | 1981 | 23 | 0.000 |
Why?
|
| Constriction, Pathologic | 1 | 1982 | 213 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1985 | 1823 | 0.000 |
Why?
|
| Placenta | 1 | 1982 | 175 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1986 | 1143 | 0.000 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1980 | 111 | 0.000 |
Why?
|
| Fetal Monitoring | 1 | 1979 | 16 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1990 | 6501 | 0.000 |
Why?
|
| Heart Defects, Congenital | 1 | 1982 | 351 | 0.000 |
Why?
|
| Fetal Distress | 1 | 1978 | 7 | 0.000 |
Why?
|
| Arrhythmia, Sinus | 1 | 1978 | 7 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1981 | 894 | 0.000 |
Why?
|
| Fetal Heart | 1 | 1978 | 13 | 0.000 |
Why?
|
| Vulva | 1 | 1978 | 23 | 0.000 |
Why?
|
| Mutation | 1 | 1987 | 3967 | 0.000 |
Why?
|
| Heart Atria | 1 | 1978 | 250 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1978 | 478 | 0.000 |
Why?
|
| Heart Rate | 1 | 1978 | 492 | 0.000 |
Why?
|
| Body Temperature | 1 | 1974 | 124 | 0.000 |
Why?
|
| Mitosis | 1 | 1974 | 153 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1974 | 684 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1974 | 1961 | 0.000 |
Why?
|